These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33801414)

  • 1. CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6.
    Chevigné A; Janji B; Meyrath M; Reynders N; D'Uonnolo G; Uchański T; Xiao M; Berchem G; Ollert M; Kwon YJ; Noman MZ; Szpakowska M
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of atypical chemokine receptor ACKR2 in experimental oral squamous cell carcinogenesis.
    da Silva JM; Dos Santos TPM; Saraiva AM; Fernandes de Oliveira AL; Garlet GP; Batista AC; de Mesquita RA; Russo RC; da Silva TA
    Cytokine; 2019 Jun; 118():160-167. PubMed ID: 29550065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors.
    Luís R; D'Uonnolo G; Palmer CB; Meyrath M; Uchański T; Wantz M; Rogister B; Janji B; Chevigné A; Szpakowska M
    Methods Cell Biol; 2022; 169():279-294. PubMed ID: 35623707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.
    Szpakowska M; D'Uonnolo G; Luís R; Alonso Bartolomé A; Thelen M; Legler DF; Chevigné A
    Front Immunol; 2023; 14():1133394. PubMed ID: 37153591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?
    Gowhari Shabgah A; Jadidi-Niaragh F; Mohammadi H; Ebrahimzadeh F; Oveisee M; Jahanara A; Gholizadeh Navashenaq J
    Front Immunol; 2022; 13():861931. PubMed ID: 35677043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical chemokine receptor ACKR2 mediates chemokine scavenging by primary human trophoblasts and can regulate fetal growth, placental structure, and neonatal mortality in mice.
    Teoh PJ; Menzies FM; Hansell CA; Clarke M; Waddell C; Burton GJ; Nelson SM; Nibbs RJ
    J Immunol; 2014 Nov; 193(10):5218-28. PubMed ID: 25297873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B.
    D'Uonnolo G; Reynders N; Meyrath M; Abboud D; Uchański T; Laeremans T; Volkman BF; Janji B; Hanson J; Szpakowska M; Chevigné A
    Front Immunol; 2022; 13():868579. PubMed ID: 35720349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and expression analysis of an atypical chemokine receptor-2 (ACKR2)/CC chemokine binding protein-2 (CCBP2) in rainbow trout (Oncorhynchus mykiss).
    Qi Z; Jiang Y; Holland JW; Nie P; Secombes CJ; Wang T
    Fish Shellfish Immunol; 2015 Jun; 44(2):389-98. PubMed ID: 25747793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.
    Metzemaekers M; Mortier A; Janssens R; Boff D; Vanbrabant L; Lamoen N; Van Damme J; Teixeira MM; De Meester I; Amaral FA; Proost P
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atypical chemokine receptor-2 fine-tunes the immune response in herpes stromal keratitis.
    Yu T; Schuette F; Christofi M; Forrester JV; Graham GJ; Kuffova L
    Front Immunol; 2022; 13():1054260. PubMed ID: 36518752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
    Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
    Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2
    Russo RC; Savino B; Mirolo M; Buracchi C; Germano G; Anselmo A; Zammataro L; Pasqualini F; Mantovani A; Locati M; Teixeira MM
    Am J Physiol Lung Cell Mol Physiol; 2018 Jun; 314(6):L1010-L1025. PubMed ID: 29469612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.
    Hewit KD; Fraser A; Nibbs RJ; Graham GJ
    J Biol Chem; 2014 May; 289(18):12330-42. PubMed ID: 24644289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22.
    Meyrath M; Reynders N; Uchański T; Chevigné A; Szpakowska M
    J Leukoc Biol; 2021 Feb; 109(2):373-376. PubMed ID: 32480426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokine scavenging receptor D6/ACKR2 is a target of miR-146a in thyroid cancer.
    Pacifico F; Lepore A; Mellone S; Sanguigno L; Federico G; Greco A; Brunetti A; Leonardi A
    Genes Cancer; 2017 May; 8(5-6):577-588. PubMed ID: 28740576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
    Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A
    Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
    Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
    Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
    Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
    J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2.
    Shams K; Kurowska-Stolarska M; Schütte F; Burden AD; McKimmie CS; Graham GJ
    J Biol Chem; 2018 Feb; 293(8):3003-3012. PubMed ID: 29279330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.